References of "Evrard, Brigitte"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailDevelopment of a non-surfactant parenteral formulation of miconazole by the use of cyclodextrins
Piel, Géraldine ULg; Evrard, Brigitte ULg; Fillet, Marianne ULg et al

in International Journal of Pharmaceutics (1998), 169

Miconazole is an antimycotic drug exhibiting a very poor water solubility (B1.03 mg:ml). It has been shown that cyclodextrins (CDs) are able to form inclusion complexes with miconazole and that they are ... [more ▼]

Miconazole is an antimycotic drug exhibiting a very poor water solubility (B1.03 mg:ml). It has been shown that cyclodextrins (CDs) are able to form inclusion complexes with miconazole and that they are able to increase its aqueous solubility. Miconazole is a weak base whose solubility depends of the pH. The purpose of this study was to investigate the influence of both CDs and different acids on the solubility of miconazole. It was found that a synergistic effect existed between CDs and different acids. The combination of hydroxypropyl-bCD (HP-bCD) (100 mM) or sulfobutylether 7-bCD (SBE7-bCD) (50 mM) and lactic acid (50 mM) allowed to dissolve more than 10 mg of miconazole per ml. NMR studies confirmed the formation of an inclusion complex miconazole–CD in an acidic medium. It was also shown by the NMR studies that the complex formed was a 1:1 complex. These results demonstrate that it is possible to develop a parenteral aqueous solution of miconazole without surfactant. [less ▲]

Detailed reference viewed: 64 (1 ULg)
Peer Reviewed
See detailAutomated determination of acyclovir in human plasma using solid phase extraction and liquid chromatography
Chiap, Patrice ULg; Planck, I.; Evrard, Brigitte ULg et al

in Journal de Pharmacie de Belgique (1998), 53

Detailed reference viewed: 17 (1 ULg)
Peer Reviewed
See detailNew developments in quantitative analysis and trace analysis in pharmaceutical matrices by FTIR
Otte, Xavier; Duvivier, France; Evrard, Brigitte ULg et al

in Proceedings de la journée de rencontre des jeunes chimistes mars 1998 (1998)

Detailed reference viewed: 12 (1 ULg)
Full Text
Peer Reviewed
See detailThe size of nanoparticles after their incorporation in gastroresistant spheroids
Duvivier, F; Grandfils, Christian ULg; Léonard, F et al

in Journal de Pharmacie de Belgique (1997), 52(3), 123

Detailed reference viewed: 10 (0 ULg)
Full Text
Peer Reviewed
See detailEtude de la taille des nanoparticules après incorporation dans des sphéroïdes gastrorésistants
Duvivier, F; Grandfils, Christian ULg; Léonard, F et al

in Journal de Pharmacie de Belgique (1997), 52(3), 123

Nanoparticles can be used as an attractive carrier for the controlled delivery of drugs by the oral route. This nanoparticular delivery system can protect an active ingredient from enzymatic degradations ... [more ▼]

Nanoparticles can be used as an attractive carrier for the controlled delivery of drugs by the oral route. This nanoparticular delivery system can protect an active ingredient from enzymatic degradations and enhance its absorption from the intestinal mucosa. We studied the development of a gastroresistant dosage form for the oral administration of nanoparticles. Fast disintegrating pellets were used for the administration of nanoparticles and for their transit to the site of absorption. A gastroresistant film was applied onto the pellets to protect the nanoparticles and/ or the active substance from the acid gastric environment. The integrity of the nanoparticle size was assessed after two critical manufacturing steps: the extrusion/spheronisation process and the coating process. The determination of the nanoparticles size distribution was performed by photon correlation spectroscopy (PCS). The comparison of the PCS results between the original nanoparticles and the nanoparticles incorporated in the pellets shows a very low aggregation. Moreover the coating process was not a critical step since it was not responsible for an additional agglomeration of the nanoparticles. In conclusion, our manufacturing process allows the redispersion of the nanoparticles with a little change of the size distribution. In a next study we well try to quantify the release of the nanoparticles from the pellets. [less ▲]

Detailed reference viewed: 16 (1 ULg)
Peer Reviewed
See detailInfluence of the amount of enteric polymer on the disintegration rate of pellets designed for protein delivery : in vitro and in vivo tests
Duvivier, France; Lubbering, B.; Léonard, Françoise ULg et al

in Proceedings of Symposium on Particulate Systems, From Formulation to Prduction (1997)

Detailed reference viewed: 8 (2 ULg)
Full Text
See detailComplexes à multicomposants de miconazole avec différents acides et cyclodextrines
Piel, Géraldine ULg; Evrard, Brigitte ULg; Delattre, Luc ULg

in Journal de Pharmacie de Belgique (1997), 52(3), 124

Detailed reference viewed: 10 (0 ULg)